Sanovas

Sanovas is a private, pre-revenue medical technology holding company founded in 2008, specializing in micro-invasive devices and targeted drug delivery for pulmonary and other conditions. The company operates by developing and spinning out specific technology platforms into separate ventures. Key challenges include its pre-commercial status, ongoing legal matters referenced on its website, and the regulatory pathway required for its investigational devices. Its strategy hinges on creating novel, minimally invasive platforms to address unmet needs in interventional pulmonology and beyond.

Platform for developing micro-invasive surgical devices and integrated targeted drug delivery systems, focusing on miniaturization for access to narrow anatomies like the lungs.

Sanovas competes in the crowded and innovative field of minimally invasive medical devices. Direct competitors include public companies like Boston Scientific (pulmonology division) and Medtronic, as well as numerous private startups developing robotic bronchoscopy, navigation platforms, and targeted lung therapy systems. Its holding company model and focus on ultra-miniaturization may differentiate it, but it lacks the commercial resources of its larger rivals.